Kegg medicus dgroup
| DG01573 | |
| DG番号 | DG01573 |
| 分類 | DGroup |
| 名称 | Calcium channel T type blocker TYPE Target |
| ステム | - |
| 構造式 |  |
| メンバー | DG00328 Mibefradil D08217 Mibefradil (INN) D05024 Mibefradil dihydrochloride (USAN) DG00803 Prilocaine D00553 Prilocaine (USP/INN); Propitocaine (JAN) D01243 Prilocaine hydrochloride (USP); Propitocaine hydrochloride (JAN) D00539 Ethosuximide (JP18/USP/INN) DG00849 Valproic acid D00399 Valproic acid (USP) D00304 Divalproex sodium (USP); Valproate semisodium (INN) D00710 Valproate sodium (USAN); Sodium valproate (JP18) D08667 Calcium valproate D00538 Zonisamide (JP18/USP/INN) D02630 Penfluridol (USAN/INN) DG01006 Flunarizine D07971 Flunarizine (INN) D01303 Flunarizine hydrochloride (JAN/USAN) DG01382 Efonidipine D07886 Efonidipine (INN) D01604 Efonidipine hydrochloride ethanolate (JAN) D01562 Aranidipine (JAN/INN) |
| 上位グループ | Cardiovascular agent DG01575 Calcium channel blocker |
| 注釈1 | - |
| 注釈2 | - |